NFKB1 and breast cancer: Syk has been shown to block breast cancer cell migration and chemoinvasion via mechanisms involving down regulation of secreted growth factor GRO-1 [6] and suppression of NF-κB, PI3K [7], Src [4], and EGFR signaling pathways [8] [see also for review, [1]].